Xenon Pharmaceuticals
XENE
XENE
289 hedge funds and large institutions have $5.8B invested in Xenon Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 124 increasing their positions, 60 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
17% more funds holding
Funds holding: 246 → 289 (+43)
11.18% more ownership
Funds ownership: 109.29% → 120.48% (+11%)
8% less call options, than puts
Call options by funds: $127M | Put options by funds: $138M
Holders
289
Holding in Top 10
12
Calls
$127M
Puts
$138M
Top Buyers
| 1 | +$89.4M | |
| 2 | +$87.5M | |
| 3 | +$61.4M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$59.9M |
| 5 |
DM
Deerfield Management
New York
|
+$49.5M |
Top Sellers
| 1 | -$44.9M | |
| 2 | -$34.1M | |
| 3 | -$22.4M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$20.3M |
| 5 |
Millennium Management
New York
|
-$20M |
